“This enterprise is lacking congressional support. The host of prior leaders in this policy space have left,” warn biodefense advocates pushing for renewed bipartisan commitment Jennifer Alton, President of Pathway Policy Group, delivered this stark assessment during a biodefense policy
“There’s optimism… but the challenges aren’t day to day – it can be minute to minute,” warns Gil Roth, President of the Pharma and Biopharma Outsourcing Association (PBOA), describing a pharmaceutical manufacturing sector facing unprecedented change in 2025. Gil Roth
Grant Brock Vice President of Operations discusses the services that the US-based CDMO offers.
Life sciences supply chains are moving out of China. This trend briefing, powered by SmartCube, summarises the key points you need to know.
The Pharmaceutical Supply Chain Risk Assessment Act is the latest legislation introduced in the US senate to reduce the United States’ dependence on importing drugs from foreign countries. The legislation will have government agencies investigate supply chain weaknesses, siting the
Indian pharmaceutical company Granules has opened a new packaging facility in Virginia, United States, as part of its strategy to expand its global presence and meet growing demand for its products.
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
